KC
PIII icon

Kepos Capital’s P3 Health Partners PIII Stock Holding History

Kepos Capital’s Portfolio PIII Stock Details PIII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,500
Closed -$5.18M – 662
2021
Q3 		$5.18M Hold
10,500
– – 0.35% 93
2021
Q2 		$5.19M Buy
+10,500
New +$5.15M 0.39% 128

Other funds holding PIII

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NIP
Nicholas Investment Partners Rancho Santa Fe, California $1.39B AUM 97.11% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
RCG
Rock Creek Group Washington, District of Columbia $988M AUM 8.89% 1-Year Est. Return

Kepos Capital's PIII Position: Q4 2021 in Review

Kepos Capital sold out of P3 Health Partners (PIII) in Q4 2021, closing a stake of 10,500 shares — an estimated $5.18M sold.

Kepos Capital first reported a position in PIII in Q2 2021 and held it in 2 quarters. The position peaked at $5.19M in Q2 2021. 24 funds tracked by Wall St. Rank hold PIII as of Q4 2021.

  • Kepos Capital reported no remaining P3 Health Partners position as of Q4 2021 after selling out during the quarter.
  • Kepos Capital sold 10,500 P3 Health Partners shares in Q4 2021, an estimated $5.18M.
  • Kepos Capital first reported a position in P3 Health Partners in Q2 2021 and held it in 2 quarters.
  • Kepos Capital's P3 Health Partners position peaked at $5.19M in Q2 2021.
  • 24 funds tracked by Wall St. Rank held P3 Health Partners as of Q4 2021.

Based on Kepos Capital's 13F filing for Q4 2021, filed 14 Feb 2022.